Pardes Biosciences, Inc.

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Sangamo Partners In Neurology With Lill

The pharmaceutical industry is no stranger to fierce competition, but the battle between Vertex Pharmaceuticals Incorporated ’s Incivek (telaprevir) and Merck & Co., Inc. ’s Victrelis (boceprevir) s

Initial public offerings for US biopharmaceutical companies generally slowed as 2021 drew to a close and biotechnology stock valuations continued to fall below broader stock indices. Nevertheless, thr